L-765314
目录号: PL14303 纯度: ≥99%
CAS No. :189349-50-6
商品编号 规格 价格 会员价 是否有货 数量
PL14303-5mg 5mg ¥1360.00 请登录
PL14303-10mg 10mg ¥2225.45 请登录
PL14303-25mg 25mg ¥4327.27 请登录
PL14303-50mg 50mg ¥6800.00 请登录
PL14303-100mg 100mg ¥11745.45 请登录
PL14303-200mg 200mg 询价 询价
PL14303-500mg 500mg 询价 询价
PL14303-10mM*1mLinDMSO 10mM*1mLinDMSO ¥1557.82 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
L-765314
中文别名
(S)-4-(4-氨基-6,7-二甲氧基喹唑啉-2-基)-2-(叔丁基氨基甲酰基)哌嗪-1-甲酸苄酯
英文名称
L-765314
英文别名
L-765,314;(2S)-4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-2-[[(1,1-dimethylethyl)amino]carbonyl]-1-piperazinecarboxylic acid phenylmethyl ester;Lopac0_001186;BCP30192;LP01186;L 3040;L016366;(2S)-4-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-2-[[(1,1-Dimethylethyl)amino]carbonyl]-1-piperazinecarboxylic acid, phenylmethyl ester;Benzyl 4-(4-amino-6,7-dimethoxyquinazolin-2-yl)-2-(tert-butylcarbamoyl)piperazine-1-carboxylate;L-765314
Cas No.
189349-50-6
分子式
C27H34N6O5
分子量
522.60
包装储存
Powder -20°C 3 years;4°C 2 years
产品详情
L-765314 是 α1b 肾上腺素能受体 (α1b adrenergic receptor) 的一个有效的、选择性拮抗剂,其在大鼠和人体中的 Ki 值分别为 5.4 nM 和 2.0 nM。
生物活性
L-765314 is a potent and selective α1b adrenergic receptor antagonist with K i s of 5.4 nM and 2.0 nM for rat and human α1b adrenergic receptor, respectively.
性状
Solid
IC50 & Target[1][2]
Ki: 5.4±0.6 nM (rat α1b receptor ), 2.0±0.66 nM (human α1b receptor), 50±8 nM (rat α1d receptor), 34±6 nM (human α1d receptor), 500±20 nM (rat α1b receptor ), 420±62 nM (human α1b receptor).
体外研究(In Vitro)
L-765314 exhibits two displacement sites. The high-affinity site accounts for approximately 25% of binding (IC50) 1.90 nM and represents binding to the R1b sites. The low-affinity site accounts for the residual 75% of binding (IC50) 790 nM and represents binding to the R1a sites. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
The results of plasma assayed by liquid chromatograph/mass spectrometer (LCMS) show that the mean C max of L-765314 (A322312) is 1.05 μM and the t 1/2 is 0.5 h. L-765314 shows weak potency for inhibiting the pressor response to either phenylephrine or A-61603 (AD 25 >3 mg/kg for each). On the basis of the inhibition of pressor responses to the R1a subtype selective agonist A-61603, L-765314 appears to be selective versus the R1a receptor up to a dose of 0.3 mg/kg. The results of hypotensive potency in rats show that both L-765314 and terazosin tend to decrease heart rate (about 25 bpm at 1 mg/kg iv). has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Patane MA, et al. 4-Amino-2-[4-[1-(benzyloxycarbonyl)-2(S)- [[(1,1-dimethylethyl)amino]carbonyl]-piperazinyl]-6, 7-dimethoxyquinazoline (L-765,314): a potent and selective alpha1b adrenergic receptor antagonist. J Med Chem. 1998 Apr 9;41(8):1205-8.
[2]. Tobias B?hmer, et al. The α1B-adrenoceptor subtype mediates adrenergic vasoconstriction in mouse retinal arterioles with damaged endothelium. Br J Pharmacol. 2014 Aug; 171(16): 3858–3867.
溶解度数据
In Vitro: DMSO : 50 mg/mL (95.68 mM; Need ultrasonic)配制储备液
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2